Key statistics
On Friday, Contineum Therapeutics Inc (CTNM:NSQ) closed at 19.84, -9.82% below its 52-week high of 22.00, set on Jul 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 19.91 |
---|---|
High | 20.30 |
Low | 18.65 |
Bid | 19.90 |
Offer | 21.91 |
Previous close | 20.08 |
Average volume | 77.63k |
---|---|
Shares outstanding | 25.72m |
Free float | 16.86m |
P/E (TTM) | -- |
Market cap | 510.35m USD |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Contineum Therapeutics to Present at Multiple Upcoming Investor Conferences
- Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
- Contineum Therapeutics Announces Publication of Encouraging Data in the Proceedings of the National Academy of Sciences on PIPE-307, Its M1 Receptor Selective Inhibitor, in Clinical Development for Relapse-Remitting Multiple Sclerosis
- Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors